{"component": "definition", "props": {"groups": [{"samples": [{"hash": "lYvC82y5Xc", "uri": "/contracts/lYvC82y5Xc#technical-development", "label": "Collaborative Research Agreement", "score": 26.1704312115, "published": true}, {"hash": "4PY8rvzLlyz", "uri": "/contracts/4PY8rvzLlyz#technical-development", "label": "Collaborative Research Agreement", "score": 26.1704312115, "published": true}, {"hash": "8ln4pbaG12G", "uri": "/contracts/8ln4pbaG12G#technical-development", "label": "Collaborative Research Agreement", "score": 25.2395619439, "published": true}], "size": 7, "snippet": "means any invention, discovery, composition, enhancement, technology, advancement, know-how, process, data, device, machine, material, software or any other information arising from the Program, including any such development protectable by patent, copyright, or other protection under the law and in which a Party has an ownership interest.", "snippet_links": [{"key": "other-information", "type": "definition", "offset": [151, 168]}, {"key": "the-program", "type": "clause", "offset": [182, 193]}, {"key": "the-law", "type": "clause", "offset": [286, 293]}, {"key": "a-party", "type": "clause", "offset": [307, 314]}, {"key": "ownership-interest", "type": "clause", "offset": [322, 340]}], "hash": "05e064d10c95421643e0e9813bff53be", "id": 1}, {"samples": [{"hash": "1dBgTGQXFvw", "uri": "/contracts/1dBgTGQXFvw#technical-development", "label": "License and Collaboration Agreement (Spring Bank Pharmaceuticals, Inc.)", "score": 31.7460643395, "published": true}, {"hash": "l7IOkm7QVik", "uri": "/contracts/l7IOkm7QVik#technical-development", "label": "License and Collaboration Agreement (Denali Therapeutics Inc.)", "score": 28.8658453114, "published": true}, {"hash": "fDaPLRKlmqr", "uri": "/contracts/fDaPLRKlmqr#technical-development", "label": "License and Collaboration Agreement (Denali Therapeutics Inc.)", "score": 28.819301848, "published": true}], "size": 3, "snippet": "means the use by Denali of the Licensor Background IP existing at the Effective Date, to Develop Fcabs and to generate libraries of Fcabs and/or to undertake further development of the Licensor Background IP in each case to support the development of Fcabs.", "snippet_links": [{"key": "licensor-background-ip", "type": "definition", "offset": [31, 53]}, {"key": "at-the-effective-date", "type": "clause", "offset": [63, 84]}, {"key": "to-develop", "type": "definition", "offset": [86, 96]}, {"key": "to-generate", "type": "definition", "offset": [107, 118]}, {"key": "development-of-the", "type": "clause", "offset": [166, 184]}, {"key": "each-case", "type": "definition", "offset": [211, 220]}, {"key": "the-development", "type": "clause", "offset": [232, 247]}], "hash": "4797aeebe9c3fd1d5d00a17ad5f81f8b", "id": 2}, {"samples": [{"hash": "jgKYY1nVrkl", "uri": "/contracts/jgKYY1nVrkl#technical-development", "label": "Gamma Ip Licence Agreement (Denali Therapeutics Inc.)", "score": 29.9281314168, "published": true}, {"hash": "44BESfSO611", "uri": "/contracts/44BESfSO611#technical-development", "label": "Gamma Ip Licence Agreement (Denali Therapeutics Inc.)", "score": 29.6023271732, "published": true}], "size": 2, "snippet": "means the use by Gamma of the F-star IP existing at the Effective Date, to Develop Fcabs and to generate libraries of Fcabs and/or to undertake further development of the F-star IP in each case to support the development of Fcabs.", "snippet_links": [{"key": "the-f", "type": "clause", "offset": [26, 31]}, {"key": "at-the-effective-date", "type": "clause", "offset": [49, 70]}, {"key": "to-develop", "type": "definition", "offset": [72, 82]}, {"key": "to-generate", "type": "definition", "offset": [93, 104]}, {"key": "development-of-the", "type": "clause", "offset": [152, 170]}, {"key": "each-case", "type": "definition", "offset": [184, 193]}, {"key": "the-development", "type": "clause", "offset": [205, 220]}], "hash": "c4d6a9a0ba08a775f19379753e9936d4", "id": 3}, {"samples": [{"hash": "c7wKh0Y95yP", "uri": "/contracts/c7wKh0Y95yP#technical-development", "label": "Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "5qngnGWWkGT", "uri": "/contracts/5qngnGWWkGT#technical-development", "label": "Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc)", "score": 18.0, "published": true}], "size": 2, "snippet": "Technical Development shall mean, with respect to a Drug Candidate and Products derived therefrom, activities utilizing chemical, pharmaceutical (galenical/formulation science), analytical, engineering and quality assurance principles to produce API or finished pharmaceutical products (i.e., in galenic form) corresponding to such Drug Candidate or Products for clinical or commercial use, including, without limitation, development of (a) chemical processes for manufacturing of API, (b) pharmaceutical processes for the manufacturing of finished pharmaceutical products, (c) analytical methods and testing procedures for API and finished pharmaceutical products, (d) packaging for finished pharmaceutical products, and (e) stability testing, manufacturing, validation, quality assurance, quality control and documentation standards and/or capabilities as necessary or appropriate. Technical Development shall not include any clinical development activities or preclinical safety activities (e.g., toxicology, pathology, drug metabolism, bioanalytics, pharmacokinetics and pharmacodynamics).", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [34, 49]}, {"key": "drug-candidate", "type": "definition", "offset": [52, 66]}, {"key": "quality-assurance", "type": "clause", "offset": [206, 223]}, {"key": "pharmaceutical-products", "type": "definition", "offset": [262, 285]}, {"key": "commercial-use", "type": "definition", "offset": [375, 389]}, {"key": "without-limitation", "type": "clause", "offset": [402, 420]}, {"key": "development-of", "type": "clause", "offset": [422, 436]}, {"key": "analytical-methods", "type": "definition", "offset": [578, 596]}, {"key": "testing-procedures", "type": "definition", "offset": [601, 619]}, {"key": "for-api", "type": "clause", "offset": [620, 627]}, {"key": "stability-testing", "type": "definition", "offset": [726, 743]}, {"key": "quality-control", "type": "clause", "offset": [791, 806]}, {"key": "documentation-standards", "type": "clause", "offset": [811, 834]}, {"key": "clinical-development-activities", "type": "clause", "offset": [928, 959]}], "hash": "6a2b3b01c0b12dfa935c2eb15aa8cf6a", "id": 4}, {"samples": [{"hash": "ei2NHVHwoP2", "uri": "/contracts/ei2NHVHwoP2#technical-development", "label": "Toll Manufacturing and Supply Agreement (Cellular Biomedicine Group, Inc.)", "score": 27.9883641342, "published": true}, {"hash": "2osXwJRA2Qn", "uri": "/contracts/2osXwJRA2Qn#technical-development", "label": "License and Collaboration Agreement (Cellular Biomedicine Group, Inc.)", "score": 27.7364818617, "published": true}], "size": 2, "snippet": "means any and all technical and Manufacturing-related activities, including test method development and stability testing, assay development, process development, formulation development, quality assurance and quality control development, validation and other testing, packaging development, as well as record-keeping, data and database development, management, storage, and retention activities relating to any of the foregoing.", "snippet_links": [{"key": "technical-and", "type": "clause", "offset": [18, 31]}, {"key": "related-activities", "type": "clause", "offset": [46, 64]}, {"key": "method-development", "type": "clause", "offset": [81, 99]}, {"key": "stability-testing", "type": "definition", "offset": [104, 121]}, {"key": "assay-development", "type": "definition", "offset": [123, 140]}, {"key": "process-development", "type": "definition", "offset": [142, 161]}, {"key": "formulation-development", "type": "clause", "offset": [163, 186]}, {"key": "quality-assurance-and-quality-control", "type": "clause", "offset": [188, 225]}, {"key": "other-testing", "type": "clause", "offset": [254, 267]}, {"key": "database-development", "type": "clause", "offset": [328, 348]}, {"key": "retention-activities", "type": "definition", "offset": [375, 395]}, {"key": "relating-to", "type": "definition", "offset": [396, 407]}, {"key": "the-foregoing", "type": "definition", "offset": [415, 428]}], "hash": "c01d806ba762e3b80dc409f3cfdf54ee", "id": 5}, {"samples": [{"hash": "8IiR4nHOIFA", "uri": "/contracts/8IiR4nHOIFA#technical-development", "label": "Technology Transfer Agreement (Horizon Pharma, Inc.)", "score": 21.8021902806, "published": true}, {"hash": "lpZUEs77La9", "uri": "/contracts/lpZUEs77La9#technical-development", "label": "Technology Transfer Agreement (Horizon Pharma, Inc.)", "score": 21.5859000684, "published": true}], "size": 2, "snippet": "refers to the implementation of all technical activities aimed at obtaining licences to market the Merchandise in Germany, Austria and other countries.", "snippet_links": [{"key": "technical-activities", "type": "clause", "offset": [36, 56]}, {"key": "aimed-at", "type": "definition", "offset": [57, 65]}, {"key": "other-countries", "type": "definition", "offset": [135, 150]}], "hash": "faeaafd46f1c4fc049d7519480a36515", "id": 6}, {"samples": [{"hash": "h7waLoGZ3Dr", "uri": "/contracts/h7waLoGZ3Dr#technical-development", "label": "Licensing Agreement (Spark Therapeutics, Inc.)", "score": 29.1560574949, "published": true}], "size": 1, "snippet": "means technical and CMC-related activities, including, without limitation, test method development and stability testing, assay development, process development (including life cycle management activities), formulation development, quality assurance and quality control development, validation and other testing, ActiveUS 166647742v.1 packaging development, as well as record-keeping, data and database development, management, storage and retention activities relating to any of the foregoing.", "snippet_links": [{"key": "technical-and", "type": "clause", "offset": [6, 19]}, {"key": "related-activities", "type": "clause", "offset": [24, 42]}, {"key": "without-limitation", "type": "clause", "offset": [55, 73]}, {"key": "method-development", "type": "clause", "offset": [80, 98]}, {"key": "stability-testing", "type": "definition", "offset": [103, 120]}, {"key": "assay-development", "type": "definition", "offset": [122, 139]}, {"key": "process-development", "type": "definition", "offset": [141, 160]}, {"key": "management-activities", "type": "clause", "offset": [183, 204]}, {"key": "formulation-development", "type": "clause", "offset": [207, 230]}, {"key": "quality-assurance-and-quality-control", "type": "clause", "offset": [232, 269]}, {"key": "other-testing", "type": "clause", "offset": [298, 311]}, {"key": "database-development", "type": "clause", "offset": [394, 414]}, {"key": "retention-activities", "type": "definition", "offset": [440, 460]}, {"key": "relating-to", "type": "definition", "offset": [461, 472]}, {"key": "the-foregoing", "type": "definition", "offset": [480, 493]}], "hash": "a09b6e1c4287a249a1eafec32e2b368b", "id": 7}, {"samples": [{"hash": "hsQN2Lvmg8a", "uri": "/contracts/hsQN2Lvmg8a#technical-development", "label": "Collaboration and Distribution Agreement (Forest Laboratories Inc)", "score": 23.1054072553, "published": true}], "size": 1, "snippet": "means the process development activities, other than clinical studies or supporting pre-clinical studies, which directly relate to the technical development of the Original Product, Line Extension or an Improved Product that has been included into this Agreement in accordance with Section 2.4.", "snippet_links": [{"key": "process-development-activities", "type": "clause", "offset": [10, 40]}, {"key": "clinical-studies", "type": "clause", "offset": [53, 69]}, {"key": "relate-to", "type": "definition", "offset": [121, 130]}, {"key": "the-technical", "type": "clause", "offset": [131, 144]}, {"key": "original-product", "type": "definition", "offset": [164, 180]}, {"key": "line-extension", "type": "clause", "offset": [182, 196]}, {"key": "improved-product", "type": "definition", "offset": [203, 219]}, {"key": "this-agreement", "type": "clause", "offset": [248, 262]}, {"key": "in-accordance-with", "type": "definition", "offset": [263, 281]}, {"key": "section-24", "type": "clause", "offset": [282, 293]}], "hash": "4a234a1020febddbca969d8a43bac733", "id": 8}, {"samples": [{"hash": "cF1Am98AXGL", "uri": "/contracts/cF1Am98AXGL#technical-development", "label": "Agreement (Innovative Card Technologies Inc)", "score": 18.0, "published": true}], "size": 1, "snippet": "Visa International has other partnerships that we feel would present some interesting business opportunities for you. We will make appropriate introductions to InCard in connection with powered card or other agreed-upon technologies. Any technology resulting from work undertaken by InCard in cooperation with a partner introduced by Visa shall be owned by InCard and/or such partner as they may determine. Visa will also refer new technology solution developers to InCard for evaluation.", "snippet_links": [{"key": "visa-international", "type": "definition", "offset": [0, 18]}, {"key": "other-partnerships", "type": "definition", "offset": [23, 41]}, {"key": "business-opportunities", "type": "definition", "offset": [86, 108]}, {"key": "in-connection-with", "type": "clause", "offset": [167, 185]}, {"key": "from-work", "type": "clause", "offset": [259, 268]}, {"key": "cooperation-with", "type": "clause", "offset": [293, 309]}, {"key": "owned-by", "type": "definition", "offset": [348, 356]}, {"key": "technology-solution", "type": "clause", "offset": [432, 451]}], "hash": "7ff37b9e9657d8d49445a7a1c9140180", "id": 9}, {"samples": [{"hash": "4nNGnbOWeqJ", "uri": "/contracts/4nNGnbOWeqJ#technical-development", "label": "Non Disclosure Agreement", "score": 26.1594798084, "published": true}], "size": 1, "snippet": "means any technical architecture, systems, program code, documentation, etc., which relates to the development of Archive services.", "snippet_links": [{"key": "technical-architecture", "type": "definition", "offset": [10, 32]}, {"key": "program-code", "type": "definition", "offset": [43, 55]}, {"key": "relates-to", "type": "definition", "offset": [84, 94]}, {"key": "development-of", "type": "clause", "offset": [99, 113]}, {"key": "archive-services", "type": "clause", "offset": [114, 130]}], "hash": "9081ba23d3ab0b27e4e5a084b6ad9324", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIedGVjaG5pY2FsLWRldmVsb3BtZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 24, "snippet": "means any invention, discovery, composition, enhancement, technology, advancement, know-how, process, data, device, machine, material, software or any other information arising from the Program, including any such development protectable by patent, copyright, or other protection under the law and in which a Party has an ownership interest.", "title": "Technical Development", "id": "technical-development", "examples": ["The JDC shall terminate in respect of a Research and <strong>Technical Development</strong> Plan upon completion by both Parties of their respective Research and <strong>Technical Development</strong> Plan Activities, unless the Parties otherwise agree.", "In addition, the Licensee shall keep Ascendis informed of the progress of the development of each Licensed Product against the applicable Research and <strong>Technical Development</strong> Plan at each meeting of the JDC pursuant to Clause 4.6(A).", "If to Executive, to: If to the Company, to: \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Jiangning Economic &amp; <strong>Technical Development</strong> \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 Facsimile: +\u2587\u2587 (\u2587\u2587) \u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Attention: Lu Tingxiu with a copy to: \u2587\u2587\u2587\u2587\u2587\u2587 &amp; \u2587\u2587\u2587\u2587\u2587\u2587\u2587 LLP \u2587\u2587/\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Facsimile: (\u2587\u2587\u2587) \u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Attention: \u2587\u2587\u2587\u2587\u2587 \u2587.", "The Licensee shall pay or reimburse (as applicable) Ascendis for the Research and <strong>Technical Development</strong> Plan Expenses in accordance with the schedule set forth in the Research and <strong>Technical Development</strong> Plans.", "Promptly after the Effective Date, the Parties will form a Joint Development Committee comprised of three (3) representatives of Ascendis and three (3) representatives of the Licensee for the first Research and <strong>Technical Development</strong> Plan (and will promptly form a JDC following agreement between the Parties in relation to each additional Research and <strong>Technical Development</strong> Plan).", "The following rules of \u201cAviation Related Clarifications\u201d are intended to provide clear direction to all parties to the Master Agreement: Retardant, Foam, Gel Dispensing: No foam, retardant, gel, or other suppressant may be dispensed from non-federal aircraft on Federal lands unless it is a product specifically approved by Missoula <strong>Technical Development</strong> Center (MTDC) and listed on the Qualified Products List (QPL).", "It is mandatory to comply with: - Volkswagen Environmental Policy; - <strong>Technical Development</strong> Environmental Objectives; - VW 01155 Standard (supplied vehicle parts); - Paragraphs 2.1 (Standard Purposes), 8.", "The JDC will meet at least [***] ([***]) times per year during the term of a Research and <strong>Technical Development</strong> Plan.", "The Parties shall perform and complete, or cause the performance and completion of, their respective Research and <strong>Technical Development</strong> Plan Activities, and deliver to each other a summary of the results (including raw data if reasonably requested by a Party), samples and reports arising therefrom in accordance with each Research and <strong>Technical Development</strong> Plan within [***] ([***]) days following completion thereof.", "Compute Area Work Plan and Status Report: This deliverable contains the detailed work plan of the Compute Services technical area compliant with the overall EMI <strong>Technical Development</strong> Plan."], "related": [["clinical-development", "Clinical Development", "Clinical Development"], ["commercial-development", "Commercial Development", "Commercial Development"], ["research-and-development", "Research and development", "Research and development"], ["spatial-development-framework", "spatial development framework", "spatial development framework"], ["municipal-spatial-development-framework", "municipal spatial development framework", "municipal spatial development framework"]], "related_snippets": [], "updated": "2025-07-06T21:58:29+00:00"}, "json": true, "cursor": ""}}